A Comparative Study of Ayurvedic Formulations in the Management Of Kamala

A Comparative Clinical Study To Evaluate The Efficacy of Eladi Churna And Draksha Ghrita In The Management Of Kamala W.S.R. To Impaired Liver Functions

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026061

Enrollment

Registered

2020-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified

Interventions

Intervention1: Eladi Churna: 3gm twice a day for 3 weeks (yog.ratnakar.pandu chi 11) Control Intervention1: Eladi Churna and Draksha Ghrita: 3gm twice a day for 3 weeks (yog.ratnakar.pandu chi 11) 6 g

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to undergo trial and ready to give written consent Patient presenting with classical feature of Kamala and impaired liver functions Total serum bilirubin-2 to 10 mg/dl SGOT-50 to 1000 IU/L SGPT- 50 to 1000 IU/L

Exclusion criteria

Exclusion criteria: Patient not willing for trial Patient below the age of 20 years and above 60 years Patient having malignancy and acute hepatocellular failure. Patient requiring surgical intervention(obstructive jaundice) Total serum bilirubin- 10mg/dl SGOT >1000 IU/L SGPT >1000 IU/L S.ALP >3 Times the normal

Design outcomes

Primary

Measure	Time frame
Fulfillment of subjective and objective criteriaTimepoint: 3 weeks	—

Secondary

Measure	Time frame
Fulfillment of subjective and objective criteriaTimepoint: 3 weeks	—

Countries

India

Contacts

Public ContactDr Azra Qureshi

RGGPG Ayurvedic College and Hospital ,Paprola

dr.skumarthakur@gmail.com9816195001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026